London, United Kingdom

Gordon G Weingarten


Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • London, GB (1981 - 1986)
  • Stevenage, GB (2007 - 2012)

Company Filing History:


Years Active: 1981-2012

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of Gordon G. Weingarten

Introduction

Gordon G. Weingarten is a distinguished inventor based in London, GB, renowned for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of nine patents, he has made substantial advancements in therapeutic treatments, particularly in addressing inflammation, allergy, and autoimmune conditions.

Latest Patents

One of his latest patents focuses on non-steroidal glucocorticoid inhibitors and their application in treating various conditions. The invention encompasses compounds with a specific formula, detailing a process for their preparation and the formulation of pharmaceutical compositions. These innovations offer promising solutions for the therapeutic treatment of inflammation, allergies, and skin diseases, highlighting Dr. Weingarten's commitment to enhancing healthcare through inventive science.

Career Highlights

Throughout his career, Gordon G. Weingarten has worked with prominent organizations, including Glaxo Group Limited and Glaxo Group Limited. His experience in these reputable companies has played a pivotal role in fostering his innovative spirit and shaping his contributions to pharmaceutical inventions.

Collaborations

Dr. Weingarten has collaborated with esteemed colleagues, including Stuart B. Laing and Simon John Fawcett MacDonald. These partnerships reflect his ability to work alongside talented professionals in the pursuit of groundbreaking innovations and effective therapeutic solutions.

Conclusion

Gordon G. Weingarten's dedication to innovation in the pharmaceutical sector is evident through his numerous patents and collaborations. His latest work on non-steroidal glucocorticoid inhibitors demonstrates his ongoing commitment to improving medical treatments and addressing critical health challenges. Through his continued efforts, Dr. Weingarten remains a key figure in the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…